Open Access 07.04.2017 | Erratum
Erratum to: First-in-human phase I study of SOR-C13, a TRPV6 calcium channel inhibitor, in patients with advanced solid tumors
Erschienen in: Investigational New Drugs | Ausgabe 3/2017
Einloggen, um Zugang zu erhalten